Patents by Inventor Judith Schenk

Judith Schenk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180055888
    Abstract: The invention encompasses compositions and method of treating a vascular disease such as peripheral artery disease, The methods involve—administering to a patient in need thereof, an effective amount of a composition comprising a population of cells such as mesenchymal stem cells (MSCs) and a non-muscle myosin 0 antagonist such as blebbistatin. Non-muscle myosin II antagonists are disclosed to surprisingly and dramatically accelerate MSC-triggered regeneration of damaged tissues arid unexpectedly and drastically reduce severe complications of stem cell treatment.
    Type: Application
    Filed: August 28, 2017
    Publication date: March 1, 2018
    Inventors: CHRISTIAN VAN DEN BOS, BARBARA REINISCH, JUDITH SCHENK, CLAUDIA ROSENBAUM
  • Publication number: 20160030482
    Abstract: The invention encompasses compositions and method of treating a vascular disease such as peripheral artery disease, The methods involve—administering to a patient in need thereof, an effective amount of a composition comprising a population of cells such as mesenchymal stem cells (MSCs) and a non-muscle myosin 0 antagonist such as blebbistatin. Non-muscle myosin II antagonists are disclosed to surprisingly and dramatically accelerate MSC-triggered regeneration of damaged tissues arid unexpectedly and drastically reduce severe complications of stem cell treatment.
    Type: Application
    Filed: March 13, 2014
    Publication date: February 4, 2016
    Applicant: LONZA COLOGNE GMBH
    Inventors: Christian VAN DEN BOS, Barbara REINISCH, Judith SCHENK, Claudia ROSENBAUM
  • Publication number: 20150329826
    Abstract: Methods and compositions for improved cell growth and serum-reduced or -free cell culture media.
    Type: Application
    Filed: December 12, 2013
    Publication date: November 19, 2015
    Inventors: Christian VAN DEN BOS, Alexis BOSSIE, Silke BRILL, Agnieszka SAFAVI-NAB, Frank JUENGERKES, Barbara REINISCH, Claudia ROSENBAUM, Judith SCHENK
  • Publication number: 20130295669
    Abstract: The invention relates to a method for promoting the adhesion of cells to a substrate to which these cells usually have no or only low affinity, wherein the adhesion of the cells to the substrate is promoted by supplying the cells with the non-muscle myosin II inhibitor Blebbistatin so as to enable the cells to attach to surfaces to which they otherwise would not have sufficient affinity. Surprisingly, supplying the cells with the inhibitor enhances the capability of these cells to attach to surfaces to which they usually have no or only low affinity, for example, PTFE (Teflon®). The invention further concerns uses of the non-muscle myosin II inhibitor Blebbistatin and devices having at least one surface which is coated with cells that have no or only low affinity to said surface.
    Type: Application
    Filed: November 9, 2011
    Publication date: November 7, 2013
    Applicant: LONZA COLOGNE GMBH
    Inventors: Judith Schenk, Christian Van Den Bos, Claudia Rosenbaum, Ying Nie